Accéder au contenu
MilliporeSigma

Principaux documents

Voir toute la documentation

870273P

Avanti

18:1 Biotinyl Cap PE

Avanti Research™ - A Croda Brand

Synonyme(s) :

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

Formule empirique (notation de Hill) :
C57H102N4O11PNaS
Numéro CAS:
384835-51-2
Poids moléculaire :
1105.47
MDL number:
MFCD22495346
UNSPSC Code:
12352211
NACRES:
NA.25
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

18:1 Biotinyl Cap PE, Avanti Research™ - A Croda Brand 870273P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 2 × 100 mg (870273P-200mg), pkg of 1 × 25 mg (870273P-25mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 870273P

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@@](COP([O-])(OCCNC(CCCCCNC(CCCC[C@](SC[C@@]1(NC(N2)=O)[H])([C@]12[H])[H])=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]

InChI

1S/C57H103N4O11PS.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-33-41-54(64)69-46-49(72-55(65)42-34-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-71-73(67,68)70-45-44-59-53(63)39-32-31-37-43-58-52(62)40-36-35-38-51-56-50(48-74-51)60-57(66)61-56;/h17-20,49-51,56H,3-16,21-48H2,1-2H3,(H,58,62)(H,59,63)(H,67,68)(H2,60,61,66);/q;+1/p-1/b19-17-,20-18-;/t49-,50+,51+,56+;/m1./s1

InChI key

VQSGNVZURNOPBT-XEAQQBNDSA-M

General description

18:1 Biotinyl Cap PE, also known as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) is a head group modified lipid containing biotinyl cap PE.

Application

18:1 Biotinyl Cap PE may be used in giant unilamellar vesicles (GUVs) and black lipid membranes (BLMs) preparation.

Packaging

5 mL Clear Glass Sealed Ampule (870273P-200mg)
5 mL Clear Glass Sealed Ampule (870273P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Still not finding the right product?

Explore all of our products under

Classe de stockage

11 - Combustible Solids

wgk

WGK 3

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

David K Y Zhang et al.
Nature protocols, 15(3), 773-798 (2020-01-15)
Synthetic antigen-presenting cells (APCs) are used to mediate scalable ex vivo T-cell expansion for adoptive cell therapy. Recently, we developed APC-mimetic scaffolds (APC-ms), which present signals to T cells in a physiological manner to mediate rapid and controlled T-cell expansion.
Yanqi Yu et al.
ACS nano (2018-11-14)
Understanding the binding of nanoparticles to receptors on biomembranes is critical to the development and screening of therapeutic materials. A prevailing understanding is that multivalent ligand-receptor binding leads to slower and confined translational motion of nanoparticles. In contrast, we report
Florian Schlosser et al.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 370(1661), 20140028-20140028 (2014-12-24)
Cells are sensitive to mechanical cues from their environment and at the same time generate and transmit forces to their surroundings. To test quantitatively forces generated by cells not attached to a substrate, we used a dual optical trap to
Afficher tous les articles scientifiques apparentés

Numéro d'article de commerce international

RéférenceGTIN
870273P-200MG04061835186891
870273P-25MG04061835186907